While claims about the benefits of Vivitrol were clearly presented in the ad, serious risks, such as vulnerability to opioid overdose, were not communicated.
A recent study published by the Centers for Disease Control and Prevention analyzed how rates of overdose deaths changed between 2015 and 2017 in people aged 18 years and older.
Mind-body therapies were linked with small declines in opioid dose, a promising finding in light of concerns surrounding the scale of opioid prescriptions in the United States.
Researchers sought to describe the practice patterns of NPs and PAs, understand the barriers these providers face in providing buprenorphine treatment, and compare them with their physician counterparts and across varying levels of practice autonomy.
Opioid overdose victims who suffer cardiac arrest are distinctly different from other cardiac arrest patients, yet they may be more likely than others to survive long enough to be admitted to a hospital.
Preexisting mental health conditions, use of tramadol, and higher number of dispensed tablets were associated with an increased risk for opioid overdose in adolescents.